State Of Wisconsin Investment Board G1 Therapeutics, Inc. Transaction History

State Of Wisconsin Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.19 - $13.5 $222,915 - $579,838	42,951 New	42,951 $233,000
Q2 2022 Aug 15, 2022	BUY	$4.04 - $8.51 $346,228 - $729,307	85,700 Added 186.71%	131,600 $650,000
Q1 2021 May 17, 2021	SELL	$17.58 - $32.59 $14,063 - $26,072	-800 Reduced 1.71%	45,900 $1.1 Million
Q4 2020 Feb 03, 2021	SELL	$10.99 - $20.4 $63,742 - $118,319	-5,800 Reduced 11.05%	46,700 $840,000
Q2 2020 Aug 12, 2020	BUY	$9.57 - $24.37 $2,871 - $7,311	300 Added 0.57%	52,500 $1.27 Million
Q1 2020 May 06, 2020	BUY	$9.07 - $26.32 $12,698 - $36,848	1,400 Added 2.76%	52,200 $575,000
Q3 2019 Nov 12, 2019	BUY	$22.78 - $40.58 $451,044 - $803,484	19,800 Added 63.87%	50,800 $1.16 Million
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $11,221 - $21,770	700 Added 2.31%	31,000 $950,000
Q1 2019 May 13, 2019	BUY	$14.4 - $21.45 $128,160 - $190,905	8,900 Added 41.59%	30,300 $503,000
Q4 2018 Feb 11, 2019	BUY	$16.51 - $51.33 $9,906 - $30,798	600 Added 2.88%	21,400 $410,000
Q2 2018 Aug 03, 2018	BUY	$35.06 - $51.17 $729,248 - $1.06 Million	20,800 New	20,800 $904,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.